CTLA-4 Inhibitor – Research Path

Short timeline of when CTLA-4 Inhibitors were initially developed here

Short Summary of development and some datapoints regarding CTLA-4 Inhibitors

Course Content

Adding a CTLA-4 Inhibitor in combination with Anti-PD1 and Multi-Kinase inhibitor led to an unprecedented response rate of 40% in chemotherapy-resistant metastatic colorectal cancer

Not Enrolled

Login to Enroll

Free

Course Includes

1 Lesson